CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome (Q32052254)

5 July 2017

title

CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome (English)

1 reference

5 July 2017

main subject

restless legs syndrome

0 references

0 references

1

Earley CJ

1 reference

5 July 2017

3

Allen RP

1 reference

5 July 2017

Hyland K

2

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

16

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

144-149

1 reference

Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Levodopa in restless legs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Dystonia with marked diurnal variation associated with biopterin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Concentration gradients of monoamine metabolites in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Amine Metabolites in Human Cerebrospinal Fluid: Effects of Cord Transection and Spinal Fluid Block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Restless legs syndrome and paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Levodopa-induced myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: a comparison between akineto-rigid and tremor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Tetrahydrobiopterin cofactor biosynthesis: GTP cyclohydrolase I mRNA expression in rat brain and superior cervical ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Hydroxylase Cofactor Activity in Cerebrospinal Fluid of Normal Subjects and Patients with Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats--influence on dopaminergic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Cerebrospinal Fluid Concentrations of Pterins and Metabolites of Serotonin and Dopamine in a Pediatric Reference Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

21 January 2018

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Restless legs syndrome treatment with dopaminergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Spinal Cord Mechanisms in Amitriptyline Responsive Restless Legs Syndrome in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

5-HIAA and HVA in CSF in patients with idiopathic pain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200101%2916%3A1%3C144%3A%3AAID-MDS1009%3E3.0.CO%3B2-F

10.1002/1531-8257(200101)16:1<144::AID-MDS1009>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference